Your browser does not support JavaScript or it may be disabled!
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
Get Realtime News
on your webpage

About 822 results for "gsk consumer"

GSK fires SA exec who raised race complaint
Eye Witness News

Glaxo Fires Executive Who Raised South Africa Race Complaint

GlaxoSmithKline Plc (GSK) dismissed an executive from its African consumer healthcare division for refusing to submit to a performance plan that was initiated a week after he reported alleged racial discrimination to a confidential integrity ... Bloomberg, 1 day ago
GSK fires SA exec who raised race complaint Eye Witness News, 21 hours ago

9 images for gsk consumer

Money Today, 3 weeks ago
The Star (Kenya), 3 weeks ago
Club of Mozambique, 9 hours ago
NDTV Profit, 3 weeks ago
Business Standard, 3 weeks ago
Business Standard, 3 weeks ago, 3 weeks ago
Engineers Journal, 1 month ago
FirstWord Pharma, 1 month ago
Business Standard

GSK Consumer Healthcare net rises 9% to ₹160 crore

GlaxoSmithKline Consumer Healthcare registered a 9 per cent increase in its net profit to ₹160 crore for the quarter ended September 30, against ₹146.93 crore in the corresponding quarter of the last fiscal. Net sales grew 11 per cent to ...
 Hindu Business Line3 weeks ago GSK standalone net up 9% in July-Sept quarter  Business Standard3 weeks ago GSK Consumer Healthcare reports 9% rise in Q2 profit  Business Today India3 weeks ago GSK Consumer Healthcare Q2 Net up 9 pc at Rs 160.29 crore  Business Standard3 weeks ago

GLAXOSMITHKLINE : Gsk turns a great leveller for its md

GlaxoSmithKline ( GSK) Consumer Healthcare has removed cabins, cubicles and most fixed workstations at its new headquarters in Gurgaon, India . Its managing director (MD) Zubair Ahmed sits with everyone else in the office, which has an open ...
 4 Traders2 weeks ago At This Office You Can Check If The CEO Is Playing Candy Crush  Indiatimes2 weeks ago GSK gets rid of cabins, cubicles at its new India HQ  Economic Times2 weeks ago Flexible workplace: GSK gets rid of cabins!  Economic Times2 weeks ago

GSK Consumer: Rich valuations fail to capture volume pressures

GlaxoSmithKline Consumer Healthcare (GSK Consumer)'s September 2014 quarter results were a tad short of street expectations. The company's sales grew 10.6% year-on-year to Rs 1,075 crore while net profit stood at Rs 160 crore, up 9.1% versus Bloomberg ...
 Business Standard3 weeks ago GSK says naira volatility driving costs as consumer stocks earnings dip  Business Day Nigeria3 weeks ago

GSK Consumer Healthcare edges up after decent quarterly earnings

GlaxoSmithkline Consumer Healthcare rose 0.74% to Rs 5,581.10 at 14:39 IST on BSE after net profit rose 9.09% to Rs 160.29 crore on 11.15% growth in total income to Rs 1175.46 crore in Q2 September 2014 over Q2 September 2013. The result was ...
 Capital Market3 weeks ago
Business Standard

Another Indian gets global MNC role

GSK Consumer's Zubair Ahmed to head Asia-Pacific, West Asia and Africa regions for proposed JV with Novartis BS Reporter | Mumbai October 9, 2014 Last Updated at 00:32 IST Zubair Ahmed, senior vice-president, Indian sub-continent, GlaxoSmithKline Consumer ...
 Business Standard1 month ago GSK Consumer: Zubair Ahmed appointed as head of Asia Pacific, Middle East and Africa  Money Control1 month ago GSKCH picks Zubair Ahmed for global role in JV with Novartis  The Financial Chronicle1 month ago GSK Consumer's Zubair Ahmed to take up regional role next year  Business Standard1 month ago
American Banking News

Buy GSK Consumer; target of Rs 5815: Firstcall Research

Brokerage house Firstcall Research is bullish on GlaxoSmithKline Consumer Healthcare and has recommended buy rating on the stock with a target price of Rs 5815 in its research report dated September 25, 2014.
 Money Control1 month ago GlaxoSmithKline plc (GSK) Research Analysts Recent Ratings Updates  Mideast Time1 month ago Recent Analysts Ratings Updates for GlaxoSmithKline plc (GSK)  American Banking News1 day ago

Novartis cuts more jobs at U.S. consumer plant ahead of handing it off to GSK

Novartis ($NVS) is into Phase III at its Lincoln, NE-based consumer health plant--phase three of its job cuts there as it whittles the workforce by 40%. The latest, and final, round of cuts comes even as the company readies its consumer health ...
 FiercePharmaManufacturing3 weeks ago Regulatory update on transaction with Novartis  London Stock Exchange1 day ago Novartis : GSK -Regulatory update on transaction with Novartis  4 Traders1 day ago Publication of Circular and Notice of General Meeting relating to the proposed major transaction with Novartis  Noodls4 days ago

Funds Available for Research Into Non-Communicable Diseases

GlaxoSmithKline (GSK), the British multinational pharmaceutical, biologics, vaccines and consumer healthcare company, has launched the first call for proposals for its Africa NCD Open Lab, to support much-needed scientific research into ...
 Individual.com1 week ago Nigeria: Funds Available for Research Into Non-Communicable Diseases  AllAfrica.com1 week ago

Exclusive - GSK China consumer healthcare unit linked to DOJ probe in 2012

Reuters | SHANGHAI/WASHINGTON September 9, 2014 Last Updated at 09:53 IST By Adam Jourdan and Aruna Viswanatha SHANGHAI/ WASHINGTON (Reuters) - A U.S. anti-bribery probe into GlaxoSmithKline Plc touched on the firm's Chinese consumer healthcare business in ...
 Business Standard2 months ago GSK China consumer healthcare unit linked to Department of Justice probe in 2012  Economic Times2 months ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts


Realtime News

on your Webpage

Add Widget >Get your members hooked!
Get updated on latest news & your favorite topics right in your inbox!
More     Less